The panel backed the vaccine, known as mFLUSIVA, for adults aged 50 years and older, concluding that its benefits outweigh ...
A Food and Drug Administration advisory panel on Thursday recommended the approval of Moderna’s mRNA-based flu shot for older ...
Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and ...